Published in Br J Pharmacol on June 01, 1995
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science (1986) 4.44
Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron (1992) 4.24
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 2.99
Long-term depression. Annu Rev Neurosci (1989) 2.64
Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev (1993) 2.45
Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation. Trends Neurosci (1993) 2.32
Synapses as associative memory elements in the hippocampal formation. Brain Res (1979) 2.18
Associative long-term depression in the hippocampus induced by hebbian covariance. Nature (1989) 2.03
Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res (1984) 1.81
Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents. Mol Pharmacol (1991) 1.73
Stable depression of potentiated synaptic responses in the hippocampus with 1-5 Hz stimulation. Brain Res (1990) 1.64
Quisqualate receptors are specifically involved in cerebellar synaptic plasticity. Nature (1987) 1.53
Short- and long-term synaptic depression in rat neostriatum. J Neurophysiol (1993) 1.51
Long-term synaptic depression in the mammalian brain. Neuron (1994) 1.51
Long-term depression of parallel fibre synapses following stimulation of climbing fibres. Brain Res (1985) 1.34
Synaptic plasticity in an in vitro slice preparation of the rat nucleus accumbens. Eur J Neurosci (1993) 1.17
Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum. Neurosci Lett (1992) 1.11
Initial synaptic efficacy influences induction and expression of long-term changes in transmission. Proc Natl Acad Sci U S A (1991) 1.01
Long-term potentiation and N-methyl-D-aspartate receptors in the visual cortex of young rats. J Physiol (1989) 1.00
Depression of excitatory synaptic input in rat striatal neurons. Brain Res (1993) 0.99
Nitric oxide and cGMP can produce either synaptic depression or potentiation depending on the frequency of presynaptic stimulation in the hippocampus. Neuroreport (1994) 0.94
Modulation of the GABAA receptor complex by steroids in slices of rat cuneate nucleus. Br J Pharmacol (1989) 0.92
Adenosine modulates a voltage-dependent chloride conductance in cultured hippocampal neurons. Brain Res (1990) 0.91
Weak excitation and simultaneous inhibition induce long-term depression in hippocampal CA1 neurons. J Neurophysiol (1994) 0.90
The role of NMDA receptors in long-term potentiation (LTP) and depression (LTD) in rat visual cortex. Brain Res (1991) 0.87
Induction of long-term depression and potentiation by low- and high-frequency stimulation in the dentate area of the anesthetized rat: magnitude, time course and EEG. Brain Res (1987) 0.87
NMDA Receptor-dependent Transient Homo- and Heterosynaptic Depression in Picrotoxin-treated Hippocampal Slices. Eur J Neurosci (1992) 0.84
Interaction between adenosine and GABAA receptors on hippocampal neurones. Brain Res (1994) 0.83
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 2.99
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol (1981) 2.02
Physiological roles for adenosine and adenosine 5'-triphosphate in the nervous system. Neuroscience (1981) 1.85
Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus. Nature (1981) 1.50
Increased kynurenic acid levels in Huntington's disease. Lancet (1988) 1.43
Quinolinic acid and other kynurenines in the central nervous system. Neuroscience (1985) 1.34
Efflux characteristics of isotopically labelled gamma-aminobutyric acid (GABA) and L-glutamate in the rat cuneate nucleus [proceedings]. Br J Pharmacol (1977) 1.32
Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem (2005) 1.31
The release of endothelium-derived relaxant factor is calcium dependent. Blood Vessels (1985) 1.23
Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system. J Pharmacol Exp Ther (1983) 1.19
Cortical pyramidal tract interneurones and their sensitivity to L-glutamic acid. J Physiol (1973) 1.18
Antagonism by clonidine of neuronal depressant responses to adenosine, adenosine-5'-monophosphate and adenosine triphosphate. Br J Pharmacol (1978) 1.17
Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr (2001) 1.13
Microiontophoretic studies of the effects of cylic nucleotides on excitability of neurones in the rat cerebral cortex. J Physiol (1977) 1.09
Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol (2006) 1.08
Actions of adenine dinucleotides on the vas deferens, guinea-pig taenia caeci and bladder. Eur J Pharmacol (1981) 1.08
Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol (1999) 1.08
The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol (1990) 1.07
Cholinergic mechanisms in the rat somatosensory cerebral cortex. J Physiol (1972) 1.07
Adenosine inhibition of gamma-aminobutyric acid release from slices of rat cerebral cortex. Br J Pharmacol (1980) 1.07
Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci (2007) 1.05
Glutamate as the neurotransmitter of cerebellar granule cells in the rat: electrophysiological evidence. Br J Pharmacol (1979) 1.03
Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine. Br J Pharmacol (1976) 1.02
Quinolinic acid: regional variations in neuronal sensitivity. Brain Res (1983) 1.02
Phosphonate analogues of carboxylic acids as aminoacid antagonists on rat cortical neurones. Neurosci Lett (1981) 1.02
Amino acid pharmacology in neocortical slices: evidence for bimolecular actions from an extension of the Hill and Gaddum-Schild equations. Br J Pharmacol (1988) 1.02
A DNA analysis program designed for computer novices working in an industrial-research environment. Nucleic Acids Res (1984) 1.01
Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists. Neuroscience (1998) 1.00
Blockade by amino acid antagonists of neuronal excitation mediated by the pyramidal tract. J Physiol (1976) 1.00
Cortical responses to pyramidal tract stimulation in the rat. Exp Neurol (1972) 1.00
Purine receptors in the rat anococcygeus muscle. J Physiol (1983) 1.00
Action of purine and pyrimidine nucleotides on the rat superior cervical ganglion. Br J Pharmacol (1993) 1.00
Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus. Brain Res (1996) 0.98
Adenine dinucleotide effects on rat cortical neurones. Brain Res (1981) 0.98
Are noradrenaline excitations artefacts? Nature (1971) 0.97
Amino acids as neurotransmitters of corticofugal neurones in the rat: a comparison of glutamate and aspartate. Br J Pharmacol (1979) 0.97
Tryptophan loading induces oxidative stress. Free Radic Res (2004) 0.96
Comparison of the effects of ethylenediamine analogues and gamma-aminobutyric acid on cortical and pallidal neurones. Br J Pharmacol (1982) 0.96
Blockade of striatal neurone responses to morphine by aminophylline: evidence for adenosine mediation of opiate action. Br J Pharmacol (1980) 0.95
Activation of Rho GTPases by synaptic transmission in the hippocampus. J Neurochem (2003) 0.94
Neuronal responses to ethylenediamine: preferential blockade by bicuculline. Neurosci Lett (1981) 0.93
Ethylenediamine as a specific releasing agent of gamma-aminobutyric acid in rat striatal slices. J Neurochem (1982) 0.93
Neuronal responses to extracellularly applied cyclic AMP:Role of the adenosine receptor. Experientia (1978) 0.93
Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro. Eur J Pharmacol (1998) 0.93
A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro. Br J Pharmacol (1988) 0.92
The effect of theophylline on essential tremor: the possible role of GABA. Pharmacol Biochem Behav (1991) 0.91
Effect of changing extracellular levels of magnesium on spontaneous activity and glutamate release in the mouse neocortical slice. Br J Pharmacol (1989) 0.90
Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol (1995) 0.90
The activity of phosphorothioate analogues of ATP in various smooth muscle systems. Br J Pharmacol (1985) 0.90
The role of kynurenines in diabetes mellitus. Med Hypotheses (1985) 0.90
Isomers of 2-amino-7-phosphonoheptanoic acid as antagonists of neuronal excitants. Neurosci Lett (1982) 0.90
Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology (Berl) (1996) 0.89
Long-term potentiation protects rat hippocampal slices from the effects of acute hypoxia. Brain Res (2001) 0.89
Cyclic AMP and cyclic GMP may mediate opposite neuronal responses in the rat cerebral cortex. Science (1975) 0.89
Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res (1998) 0.89
An electrophysiological demonstration of a synergistic interaction between norepinephrine and adenosine in the cerebral cortex. Brain Res (1978) 0.88
The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid. Br J Pharmacol (1981) 0.88
Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo. Br J Pharmacol (1988) 0.88
Inhibition by purines of the inotropic action of isoprenaline in rat atria. Br J Pharmacol (1983) 0.88
Distribution of Rho family GTPases in the adult rat hippocampus and cerebellum. Brain Res Mol Brain Res (2003) 0.88
The effect of kainic, quinolinic and beta-kainic acids on the release of endogenous amino acids from rat brain slices. Biochem Pharmacol (1986) 0.87
Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists. Br J Pharmacol (2002) 0.87
Neurotoxicity of tryptophan metabolites. Biochem Soc Trans (2007) 0.87
Effects of topically applied excitatory amino acids on evoked potentials and single cell activity in rat cerebral cortex. Eur J Pharmacol (1986) 0.87
Nitric oxide synthase inhibitors L-NAME and 7-nitroindazole protect rat hippocampus against kainate-induced excitotoxicity. Neurosci Lett (1998) 0.86
Coenzyme A or adenosine inhibiting acetylcholine release? Nature (1978) 0.86
Increased long-term potentiation in the CA1 region of rat hippocampus via modulation of GTPase signalling or inhibition of Rho kinase. Neuropharmacology (2004) 0.86
The mouse neocortical slice: preparation and responses to excitatory amino acids. Comp Biochem Physiol C (1987) 0.86
Characterization of the adenosine receptors of the rat superior cervical ganglion. Br J Pharmacol (1993) 0.86
A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effects on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat. Br J Pharmacol (1991) 0.86
Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci (1997) 0.86
Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation. J Neurol Sci (1999) 0.86
Uptake and calcium-dependent release of ethylenediamine (1,2-diaminoethane) by rat brain slices. J Neurochem (1982) 0.86
Presynaptic actions of adenosine are magnesium-dependent. Neuropharmacology (1988) 0.85
4-Aminopyridine blockade of neuronal depressant responses to adenosine triphosphate. Br J Pharmacol (1980) 0.85
Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis. Clin Exp Rheumatol (2005) 0.85
Is adenosine the mediator of opiate action on neuronal firing rate? Nature (1979) 0.85
On the mechanism of action of clonidine: effects on single central neurones. Br J Pharmacol (1974) 0.85
The effects of cyclic dicarboxylic acids on spontaneous and amino acid-evoked activity of rat cortical neurones. Br J Pharmacol (1982) 0.85
Characteristics of the release of adenosine from slices of rat cerebral cortex. J Physiol (1980) 0.84
Increased expression of dendritic mRNA following the induction of long-term potentiation. Brain Res Mol Brain Res (1998) 0.84
Activation of thermogenesis of brown fat in rats by baclofen. Neuropharmacology (1986) 0.84
Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease. Brain Res Bull (2004) 0.84
Cell-membrane receptors for purines. Review. Biosci Rep (1982) 0.84
Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury. J Neurochem (2006) 0.84
Differential blockade of ATP, noradrenaline and electrically evoked contractions of the rat vas deferens by nifedipine. Eur J Pharmacol (1981) 0.83
Interaction between adenosine and GABAA receptors on hippocampal neurones. Brain Res (1994) 0.83
A comparison of the anticonvulsant potency of (+/-) 2-amino-5-phosphonopentanoic acid and (+/-) 2-amino-7-phosphonoheptanoic acid. Neuroscience (1983) 0.83
Therapeutic and "dose-dependent" effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease. J Neurosci Res (1999) 0.83
Interactions of adenosine and magnesium on rat hippocampal slices. Brain Res (1988) 0.83
Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo. Br J Pharmacol (1992) 0.82
Noradrenaline effects and pH. J Pharm Pharmacol (1972) 0.82
Ethylenediamine and GABA potentiation of [3H]diazepam binding to benzodiazepine receptors in rat cerebral cortex. J Neurochem (1982) 0.82
Clonidine as an adenosine antagonist. J Pharm Pharmacol (1978) 0.82
Possible roles for purine compounds in neuronal adaptation. Biochem Soc Trans (1978) 0.82
Changes in adenosine sensitivity in the hippocampus of rats with streptozotocin-induced diabetes. Br J Pharmacol (1992) 0.82
Pharmacological receptors and the control of cell function. Arch Int Pharmacodyn Ther (1974) 0.82
Characterisation of ATP-induced facilitation of transmission in rat hippocampus. Eur J Pharmacol (2000) 0.82
Activation of NMDA receptor-coupled channels suppresses the inhibitory action of adenosine on hippocampal slices. Brain Res (1990) 0.82
Effects of anticonvulsants on responses to excitatory amino acids applied topically to rat cerebral cortex. Gen Pharmacol (1988) 0.82